Severe COVID‐19 is often accompanied by coagulopathies such as thrombocytopenia and
abnormal clotting. Rarely, such complications follow SARS‐CoV‐2 vaccination. The cause …

COVID-19 patients often develop coagulopathies including microclotting, thrombotic strokes
or thrombocytopenia. Autoantibodies are present against blood-related proteins including …

We report a patient with severe Covid-19-associated coagulopathy and type 2 diabetes
mellitus who tested positive for antiphospholipid antibodies (aPL). Analysis of skin …

Advanced SARS-CoV-2 infections not uncommonly associate with the occurrence of silent
or manifest thrombotic events which may be found as focal or systemic disease. Given the …

Vascular endothelial injury is a hallmark of acute infection at both the microvascular and
macrovascular levels. The hallmark of SARS‐CoV‐2 infection is the current COVID‐19 …

By examining the issue of the thromboses and hemostasis disorders associated with severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) through the lens of cross …

Abstract In coronavirus disease 2019 (COVID-19), multiple thromboinflammatory events
contribute to the pathophysiology, including coagulation system activation, suppressed …

COVID-19 is characterized by dysregulated thrombosis and coagulation that can increase
mortality in patients. Platelets are fast responders to pathogen presence, alerting the …

In severe cases of coronavirus disease 2019 (COVID-19), patients may develop abnormal
blood clots—from pulmonary embolismsinthelungsanddeepveinthrombo… in the legs, to …

A subset of patients with coronavirus disease 2019 (COVID-19) become critically ill,
suffering from severe respiratory problems and also increased rates of thrombosis. The …